MENS — Jyong Biotech Share News
0.000.00%
Last trade - 00:00- $131.39m
- $148.66m
NASDAQ RESUMED AT 11:58 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:53 AM
NASDAQ RESUMED AT 11:53 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:48 AM
NASDAQ RESUMED AT 11:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:42 AM
NASDAQ RESUMED AT 11:42 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:32 AM
NASDAQ RESUMED AT 11:25 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:15 AM
Brief: Jyong Biotech Expands Regional Partnerships, Signs MoU With A Vietnam Pharmaceutical Distributor
Brief: Jyong Biotech Announces Completion Of Primary Endpoint Statistical Analysis For Phase Ii Clinical Trial Of Mcs-8 With Positive Outcomes
Brief: Jyong Biotech Completes Phase II Enrollment Of 700+ Patients For MCS‑8 In Prostate Cancer Prevention Trial
Brief: Jyong Biotech announces closing of $20 million IPO
Brief: Jyong Biotech Ltd Prices IPO At $7.50 Per Share
Brief: Jyong Biotech Sees U.S. IPO Of Up To 2.35 Mln Ordinary Shares
Brief: Jyong Biotech Ltd Files To Withdraw U.S. IPO Plans